PerfectSwell(R) Zion To Start Construction
17.4.2025 13:05:00 CEST | ACCESS Newswire | Press Release
Generation 6 Technology Set for Southern Utah
SOLANA BEACH, CA / ACCESS Newswire / April 17, 2025 / American Wave Machines, the global leader in world-class surf pool destinations, announces a new project, PerfectSwell® Zion, a mixed-use development in Washington, Utah, the outdoor activity hub adjacent to Zion National Park. AWM is partnering with Desert Lakes LLC on the project. The commercial surf park anchors a luxury residential community called Zion Shores offering waterfront single family homes and beachfront townhouses. PerfectSwell® Zion will be open to the public with Zion Shores residents enjoying unique perks and surf priority. PerfectSwell® Zion opens in Q1 2027.
Capping four years of in-house R&D, the project will feature Generation 6 PerfectSwell® surf technology bringing bigger, better waves, improved efficiency, cutting-edge sustainability features, and AWM's most innovative wave package yet. Gen 6 features optimization diagnostics utilizing historic and real time data, innovative health monitoring, maintenance schedules, and a thermal design system for air and water temperature management. Further improvements in pneumatics have resulted in measurable increases in wave generating efficiency. In terms of design, natural and permanent elements will be utilized for energy dissipation in the water minimizing the use of fabricated materials. For the surf and aquatics recreation, the project will upcycle brackish water - unfit for drinking or farming - conserving fresh water and reducing waste.
"We have just about every outdoor activity you can think of in this high desert playground except surfing. We're stoked to partner with AWM to change that. The team behind PerfectSwell® is the real deal," said Cody Larkin, CEO of Desert Surf, LLC. "AWM makes the type of waves they want to surf with a mandate of continuing innovation. We're ready to go."
"Gen 6 PerfectSwell® is next level, and I can't think of a better location for the debut or a better partner in the US. Desert Lakes brings a wealth of expertise in civil construction and community infrastructure building, essential for a successful project," said Bruce McFarland, President of AWM. "We're thrilled to work with Cody and his team to expand our global network of deeply connected surf communities to Utah and beyond."
About American Wave Machines
American Wave Machines, Inc.is the inventor and developer of PerfectSwell® Surf Technology. AWM's technology powers world class surf facilities and destinations backed by proven financials, extensive data capture, and stoked surfers. PerfectSwell® is the only sequence based, pneumatic surf technology on the market. Protected by over 50 patents worldwide, PerfectSwell® Split Peaks, Peeling Waves, Air Sections, and Wedge Barrels are all covered by AWM's robust patent portfolio.
About Desert Lakes LLC
Desert Lakes LLC is a dynamic partnership between Immaculate Homes and Salt Lake Excavating, formed in 2019 to develop the renowned Southern Shores community in Hurricane Utah. This unique waterfront development features three man-made lakes designed for boating, surfing, and a variety of recreational activities, all surrounded by premium residential properties. Cody Larkin brings extensive expertise in civil construction and lake development, while Jason and Brittany Christensen of Immaculate Homes lead the charge on vertical construction, combining their strengths to create one-of-a-kind living experiences.
Contact:
Jenna Timinsky
info@americanwavemachines.com
SOURCE: American Wave Machines, Inc.
View the original press release on ACCESS Newswire
American Wave Machines, Inc.

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities9.2.2026 06:00:00 CET | Press Release
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons Vesalic is pioneering a novel therapeutic to intercept and neutralise these toxins, potentially slowing or halting progression of monogenic and sporadic forms of ALS In addition, Vesalic has discovered a disease-specific alteration of the lipid composition in the membranes of exosomes circulating in the blood, and has developed a highly accurate biomarker-based technology to detect both monogenic and sporadic ALS Based on its novel biomarker discoveries, Vesalic is also applying its biomarker technology for other neurodegenerative diseases, including Alzheimer's and Parkinson's LONDON, UK / ACCESS Newswire / February 9, 2026 / Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press Release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press Release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press Release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press Release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom